Stoke Therapeutics, Inc. (STOK) Revenue Growth
Stoke Therapeutics, Inc. (STOK) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | -29.22% |
| 2024-12-31 | 316.34% |
| 2025-12-31 | 404.50% |
How STOK compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| TXMD | TherapeuticsMD Inc. | 71.61% |
| RIGL | Rigel Pharmaceuticals Inc. | 64.15% |
| AKBA | Akebia Therapeutics Inc. | 47.46% |
| RFL | Rafael Holdings Inc. Class B | 43.96% |
| ARRY | Array Technologies Inc. | 40.22% |
These are five companies in the same sector as STOK with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Stoke Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("STOK", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | STOK | $30.89 | -0.99% | 0.73M |
| 3 | ||||
| 4 | ||||
| 5 |